Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance Study To Observe The Safety And Effectiveness Of Varenicline (Champix) Tablets In Smoking Cessation Among Filipino Subjects

NCT00794365 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00794365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance Study To Observe The Safety And Effectiveness Of Varenicline (Champix) Tablets In Smoking Cessation Among Filipino Subjects
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 31, 2008
Completion date
November 30, 2009
Enrollment
330 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation